Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Transcriptional corepressor SIN3A regulates hippocampal synaptic plasticity via Homer1/mGluR5 signaling
Morgan Bridi, Hannah Schoch, Cédrick Florian, Shane G. Poplawski, Anamika Banerjee, Joshua D. Hawk, Giulia S. Porcari, Camille Lejards, Chang-Gyu Hahn, Karl-Peter Giese, Robbert Havekes, Nelson Spruston, Ted Abel
Morgan Bridi, Hannah Schoch, Cédrick Florian, Shane G. Poplawski, Anamika Banerjee, Joshua D. Hawk, Giulia S. Porcari, Camille Lejards, Chang-Gyu Hahn, Karl-Peter Giese, Robbert Havekes, Nelson Spruston, Ted Abel
View: Text | PDF
Research Article Genetics Neuroscience

Transcriptional corepressor SIN3A regulates hippocampal synaptic plasticity via Homer1/mGluR5 signaling

  • Text
  • PDF
Abstract

Long-term memory depends on the control of activity-dependent neuronal gene expression, which is regulated by epigenetic modifications. The epigenetic modification of histones is orchestrated by the opposing activities of 2 classes of regulatory complexes: permissive coactivators and silencing corepressors. Much work has focused on coactivator complexes, but little is known about the corepressor complexes that suppress the expression of plasticity-related genes. Here, we define a critical role for the corepressor SIN3A in memory and synaptic plasticity, showing that postnatal neuronal deletion of Sin3a enhances hippocampal long-term potentiation and long-term contextual fear memory. SIN3A regulates the expression of genes encoding proteins in the postsynaptic density. Loss of SIN3A increases expression of the synaptic scaffold Homer1, alters the metabotropic glutamate receptor 1α (mGluR1α) and mGluR5 dependence of long-term potentiation, and increases activation of ERK in the hippocampus after learning. Our studies define a critical role for corepressors in modulating neural plasticity and memory consolidation and reveal that Homer1/mGluR signaling pathways may be central molecular mechanisms for memory enhancement.

Authors

Morgan Bridi, Hannah Schoch, Cédrick Florian, Shane G. Poplawski, Anamika Banerjee, Joshua D. Hawk, Giulia S. Porcari, Camille Lejards, Chang-Gyu Hahn, Karl-Peter Giese, Robbert Havekes, Nelson Spruston, Ted Abel

×

Figure 7

The DHPG-mediated postburst afterdepolarization is enhanced in CA1 pyramidal neurons of Sin3aNH mice.

Options: View larger image (or click on image) Download as PowerPoint
The DHPG-mediated postburst afterdepolarization is enhanced in CA1 pyram...
(A) Example traces showing postburst behavior of CA1 pyramidal neurons before drug treatment (black, all genotypes) and after 15 minutes of drug exposure (controls, blue; Sin3aNH, red) or DHPG + MPEP (controls, yellow; Sin3aNH, purple). (B) The mean amplitude of the baseline postburst afterhyperpolarization in CA1 neurons did not differ between control and Sin3aNH animals prior to DHPG treatment (controls, n = 7; AHP amplitude = –2.201 ± 0.369 mV; Sin3aNH, n = 5; amplitude = –2.482 ± 0.450 mV; unpaired 2-tailed t test, P = 0.638). (C) The DHPG-mediated AHP-to-ADP conversion is enhanced in Sin3aNH mice relative to controls, following 15 minutes of drug exposure. The mGluR5 inhibitor MPEP (10 μM) blocks the AHP-to-ADP conversion in Sin3aNH mice when coapplied with 12 μM DHPG (controls + DHPG, n = 7 cells; ΔV = 2.43 ± 0.66 mV; Sin3aNH + DHPG, n = 5 cells; ΔV = 7.49 ± 0.84 mV; controls + DHPG + MPEP, n = 4 cells; ΔV = 0.07 ± 0.44 mV; Sin3aNH + DHPG + MPEP, n = 5 cells; ΔV = 1.05 ± 0.52 mV; 2-way ANOVA, genotype, F[1,17] = 19.40, P = 0.0004; drug, F[1,17] = 41.27, P < 0.0001; genotype × drug, F[1,17] = 8.848, P = 0.0085; Holm-Sidak’s multiple comparisons test, control + DHPG vs. Sin3aNH + DHPG, ***P = 0.0001; Sin3aNH + DHPG vs. Sin3aNH + DHPG + MPEP, ***P < 0.0001; control + DHPG + MPEP vs. Sin3aNH + DHPG, ***P < 0.0001; control + DHPG vs. control + DHPG + MPEP, P = 0.0742). Representative traces are shown before (t = 0 min) and after (t = 15 min) drug treatment. Black bar indicates time course of drug treatment (12 μM DHPG or 12 μM DHPG + 10 μM MPEP). All data are presented as mean ± SEM.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts